ArticleCancers2025

ITGA2 Mediates the Resistance of Hepatocellular Carcinoma to Lenvatinib by Activating the AKT/FOXO3A Signaling Pathway.

Kai Gong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.